LexDanaLexDanabeta
Inventor

SHANTA BANTIA

Inventor
US

Overview

5→
Patents
2021–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 5 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes28%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
C07DHeterocyclic compounds17%
Y02ATechnologies for adaptation to climate change17%
C07HSugars11%
PatentTitleYear
12,508,266Methods and compositions for inhibition of polymerase202512,121,503Antiviral treatments202411,975,003Methods and compositions for treatment of Zika virus infection202411,464,755Antiviral treatments202211,173,159Methods and compositions for inhibition of polymerase2021

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2021–2024Patents assigned to BIOCRYST PHARM INC (4)· patent assignee history
2021–2025Based in US· patent location history
2025Patents assigned to ISLAND PHARMACEUTICALS LTD (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
BIOCRYST PHARM INC42021–2024
ISLAND PHARMACEUTICALS LTD12025
Locations
LocationPatentsSpan
US52021–2025